Search
Now showing items 1-7 of 7
Comparative oncology and clinical translation of glyco protein conjugated gold nano therapeutic agent (GA-198AuNP) [abstract]
(2010)
As part of our efforts toward clinical translation of GA-198AuNP, our studies are focused on therapeutic efficacy of nanoparticulate GA198AuNP agent in dogs with prostatic carcinoma. The overall goal is to gain clinical ...
Walk A Hound, Lose A Pound, & Stay Fit for Seniors
(2010)
Background: Obesity rates in older adults are linked with the national problem of limited physical activity (PA), resulting in chronic illness. Obesity-related illness and functional loss require innovative interventions. ...
Navigating the two-way street of comparative oncology
(2010)
Companion animals offer a unique model for study of spontaneously occurring cancer for many reasons. Our pets share our environment, thus may have similar exposure to environmental carcinogens. The technology for diagnosis ...
Canine Neurodegenerative Diseases: A Bridge from Bench to Health for Humans and their Companions
(2010)
Spontaneous neurologic diseases are common in dogs and frequently there is a genetic predisposition. Advances in canine genomics and the nature of pure-bred dog populations make it possible to efficiently map and sequence ...
Shelter Dog Behavior Improvement: Dog Walking as Enrichment
(2010)
Background: Several million dogs are euthanized in animal shelters annually after multiple relinquishment reasons (Scarlett, 2002; Salman, 1998; New, 2000 & Kass, 2001). Gains in pet adoptions are happening via shelter ...
Clinical and Computational Collaboration in Orthopaedic Biomechanics
(2010)
The mission of the Comparative Orthopaedic Laboratory at the University of Missouri-Columbia (COL-UMC) is three-fold: 1.To design and conduct the highest quality hypothesis-driven research focused on orthopaedic disorders ...
Dose escalation safety study of Nanotax® in dogs [abstract]
(2010)
The goal of this project is to determine the suitability of CritiTech's existing formulation of fine-particle paclitaxel, Nanotax®, for the treatment of spontaneously-occurring cancer in dogs. The rationale behind this ...